AMHD Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.00 - $0.04
Previous CloseN/A
Volume100.00
Average Volume (3M)0.00
Market Cap
$953.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,766,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AMHD FAQ
What was HLK Biotech Holding Group Inc’s price range in the past 12 months?
HLK Biotech Holding Group Inc lowest stock price was $0.00 and its highest was $0.04 in the past 12 months.
What is HLK Biotech Holding Group Inc’s market cap?
HLK Biotech Holding Group Inc’s market cap is $953.00.
When is HLK Biotech Holding Group Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HLK Biotech Holding Group Inc’s earnings last quarter?
Currently, no data Available
Is HLK Biotech Holding Group Inc overvalued?
According to Wall Street analysts HLK Biotech Holding Group Inc’s price is currently Overvalued.
Does HLK Biotech Holding Group Inc pay dividends?
HLK Biotech Holding Group Inc does not currently pay dividends.
What is HLK Biotech Holding Group Inc’s EPS estimate?
HLK Biotech Holding Group Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HLK Biotech Holding Group Inc have?
HLK Biotech Holding Group Inc has 4,766,000 shares outstanding.
What happened to HLK Biotech Holding Group Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of HLK Biotech Holding Group Inc?
Currently, no hedge funds are holding shares in AMHD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HLK Biotech Holding Group Inc
HLK Biotech Holding Group, Inc. operates primarily through its various subsidiaries, focusing on the production and distribution of biodiesel. In addition to its energy sector activities, the company also engages in the acquisition of real estate assets. The firm was formerly recognized as Amelot Holdings, Inc., but it officially rebranded to HLK Biotech Holding Group, Inc. in February 2018. The company's principal office is located in Norfolk, Virginia.
Technical Analysis
―
Scinai Immunotherapeutics
―
Universe Pharmaceuticals
―
Akanda Corp
―
Virax Biolabs Group Ltd. Class A
―